SAN DIEGO, Feb. 21, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on February 20, 2025, the Human […]
OTTAWA, ON, Feb. 21, 2025 /PRNewswire/ – Esphera SynBio Inc. will be featured in an upcoming episode of Advancements, a television program hosted by Ted Danson and broadcast on the Bloomberg cable and satellite network. […]
SILVER SPRING, Md., Feb. 21, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, […]
PROVIDENCE, R.I., Feb. 21, 2025 /PRNewswire/ — Nabsys 2.0, LLC (Nabsys) and Hitachi High-Tech America, Inc. (HTA) have revealed the awardees of their OhmX Rapid Application to Market Penetration User Partnership, or OhmX RAMP UP, […]
STOCKHOLM, Feb. 21, 2025 /PRNewswire/ — The Board of RaySearch Laboratories AB (publ) proposes a dividend for the full-year 2024 of 3.00 SEK per share (0.70). Record day for the dividend is proposed to May 26, […]
